Try our beta test site
125 studies found for:    INCB018424
Show Display Options
Rank Status Study
21 Active, not recruiting Topical Ruxolitinib for the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Drug: Ruxolitinib 1.5% Phosphate Cream
22 Not yet recruiting Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer
Condition: Inflammatory Breast Cancer (IBC)
Interventions: Drug: Ruxolitinib;   Drug: Paclitaxel;   Drug: Doxorubicin;   Drug: Cyclophosphamide
23 Recruiting Study of Ruxolitinib Plus Decitabine in Patients With Acute Myeloid Leukemia (AML)
Conditions: Leukemia;   Myeloproliferative Diseases
Interventions: Drug: Ruxolitinib;   Drug: Decitabine
24 Recruiting A Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH1)
Condition: Graft-versus-host Disease
Interventions: Drug: Ruxolitinib;   Drug: Prednisone or methylprednisolone
25 Completed
Has Results
Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis
Conditions: Primary Myelofibrosis;   Post-Polycythemia Vera Myelofibrosis;   Post-Essential Thrombocythemia Myelofibrosis
Intervention: Drug: Ruxolitinib
26 Not yet recruiting Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients
Condition: Leukemia, Lymphocytic, Chronic, B-Cell
Interventions: Drug: ruxolitinib;   Drug: ibrutinib
27 Not yet recruiting Ruxolitinib for Premalignant Breast Disease
Conditions: Ductal Carcinoma In Situ;   Atypical Lobular Hyperplasia;   Atypical Ductal Hyperplasia;   Lobular Carcinoma In Situ
Interventions: Drug: Ruxolitinib;   Drug: Placebo (for Ruxolitinib)
28 Active, not recruiting Ruxolitinib Prior to Transplant in Patients With Myelofibrosis
Conditions: Primary Myelofibrosis;   Post Polycythemia Vera Myelofibrosis;   Post Essential Thrombocythemia Myelofibrosis
Intervention: Drug: Ruxolitinib Pre- Hematopoietic cell transplantation (HCT)
29 Recruiting TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea
Conditions: Myelofibrosis;   Polycythemia Vera
Interventions: Drug: TGR-1202;   Drug: ruxolitinib
30 Recruiting Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF
Conditions: Primary Myelofibrosis;   Secondary Myelofibrosis;   PMF;   SMF;   Post-PV MF;   Post-ET MF
Intervention: Drug: INCB018424/CC-4047
31 Active, not recruiting Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) Patients
Condition: Chronic Phase Chronic Myeloid Leukemia
Interventions: Drug: Nilotinib;   Drug: Ruxolitinib
32 Recruiting Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
Condition: Myeloproliferative Diseases
Interventions: Drug: Ruxolitinib;   Drug: Pracinostat;   Behavioral: Questionnaire
33 Completed Phase l/II Study of Ruxolitinib for Acute Leukemia
Condition: Leukemia
Intervention: Drug: Ruxolitinib
34 Active, not recruiting Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
Condition: Myeloproliferative Diseases
Interventions: Drug: Ruxolitinib;   Drug: Lenalidomide;   Drug: Prednisone
35 Recruiting Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer
Conditions: Metastatic Breast Cancer;   Breast Carcinoma;   HER-2 Positive Breast Cancer
Interventions: Drug: Ruxolitinib;   Drug: Trastuzumab
36 Active, not recruiting Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca
Conditions: Recurrent Breast Cancer;   Metastatic Breast Cancer
Interventions: Drug: Ruxolitinib;   Drug: Paclitaxel
37 Withdrawn Ruxolitinib in Combination With Autotransplant
Conditions: Myelofibrosis;   MF
Interventions: Drug: RUXOLITINIB / INC 424;   Drug: Filgrastim;   Drug: Busulfan
38 Completed Pilot Study to Evaluate the Efficacy of Ruxolitinib in Alopecia Areata
Condition: Alopecia Areata
Intervention: Drug: Ruxolitinib
39 Completed Ruxolitinib in the Treatment of Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Ruxolitinib
40 Recruiting Administration of Jakafi (Ruxolitinib) for Symptom Control of Patients With Chronic Lymphocytic Leukemia (CLL)
Condition: Leukemia
Interventions: Drug: Ruxolitinib;   Behavioral: Questionnaire

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.